Obesity in women's life: role of GLP-1 agonists

Gynecol Endocrinol. 2022 Nov;38(11):889-890. doi: 10.1080/09513590.2022.2163235. Epub 2023 Jan 4.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Female
  • Glucagon-Like Peptide 1
  • Humans
  • Hypoglycemic Agents
  • Obesity* / complications
  • Obesity* / drug therapy

Substances

  • Glucagon-Like Peptide 1
  • Hypoglycemic Agents